Venlafaxine Hydrochloride

Product NDC
71335-1812
11-digit product format
713351812
Labeler code
71335
Product ID
71335-1812_f0bd21a3-bd51-44d0-afd8-a75b9129061f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Venlafaxine Hydrochloride
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA212277
Marketing category
ANDA
Marketing start
2019-07-08
Substance
VENLAFAXINE HYDROCHLORIDE
Active strength
150 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Venlafaxine Hydrochloride
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
VENLAFAXINE HYDROCHLORIDE150 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii7D7RX5A8MO
Rxcui313581

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-1812-17133518120130 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1812-1) 2021-06-220000-00-00NoNoCurrent
71335-1812-27133518120260 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1812-2) 2021-08-200000-00-00NoNoCurrent
71335-1812-37133518120390 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1812-3) 2021-03-180000-00-00NoNoCurrent
71335-1812-471335181204100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1812-4) 2024-09-060000-00-00NoNoCurrent